Daclatasvir Dihydrochloride and Erythromycin Delayed-Release Tablet
Determining the interaction of Daclatasvir Dihydrochloride and Erythromycin Delayed-Release Tablet and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: erythromycin
Brand name: EES. Granules, EES-400 Filmtab, EryPed 200, EryPed 400, Ery-Tab, Erythrocin Lactobionate, Erythrocin Stearate Filmtab, PCE Dispertab, E. E. S, EryPed, Erythrocin, Erythromycin Filmtabs, Erythromycin Lactobionate - IV
Synonyms: Erythromycin, Erythromycin (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Erythromycin Delayed-Release Tablets and Capsules
- Daclatasvir Dihydrochloride-Erythromycin Ethyl Succinate Tablets
- Daclatasvir Dihydrochloride-Erythromycin Filmtabs
- Daclatasvir Dihydrochloride-Erythromycin Injection
- Daclatasvir Dihydrochloride-Erythromycin Intravenous
- Daclatasvir Dihydrochloride-Erythromycin Lactobionate - I.V.
- Erythromycin Delayed-Release Tablet-Daclizumab
- Erythromycin Delayed-Release Tablet-Daclizumab Subcutaneous
- Erythromycin Delayed-Release Tablet-Dacogen
- Erythromycin Delayed-Release Tablet-Dacomitinib
- Erythromycin Delayed-Release Tablet-Dactinomycin
- Erythromycin Delayed-Release Tablet-Dactinomycin Injection